Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.79
-0.02 (-1.10%)
At close: Jun 26, 2025, 3:59 PM
1.73
-3.62%
Pre-market: Jun 27, 2025, 05:56 AM EDT
-1.10% (1D)
| Bid | 1.71 |
| Market Cap | 4.05M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.52M |
| EPS (ttm) | -6.6 |
| PE Ratio (ttm) | -0.27 |
| Forward PE | -2.15 |
| Analyst | n/a |
| Ask | 1.96 |
| Volume | 220,121 |
| Avg. Volume (20D) | 1,718,175 |
| Open | 1.78 |
| Previous Close | 1.81 |
| Day's Range | 1.75 - 1.83 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.51 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
1 month ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
9 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
